Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lindsay McFarland
Institution:
Caribou Biosciences (United States)
Observed institutions:
Seattle Cancer Care Alliance,
Caribou Biosciences (United States),
Legend Biotech (United States)
OpenAlex ID:
A5066717411
The Impact of Outpatient versus Inpatient Administration of CAR-T Therapies on Clinical, Economic, and Humanistic Outcomes in Patients with Hematological Cancer: A Systematic Literature Review
2023
·
Doris K. Hansen
, Yi-Hsuan Liu
, et al.
·
Cancers
·
37
PDF
Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma
2024
·
Doris K. Hansen
, Binod Dhakal
, et al.
·
Frontiers in Immunology
·
6
Limits of the Glasgow Coma Scale When Assessing for Sepsis in Allogeneic Hematopoietic Cell Transplant Recipients
2021
·
Margaret L. Lind
, Mirta Maravilla Rosas
, et al.
·
Nursing Research
·
5
Vispa-Cel, an Allogeneic Anti-CD19 CAR-T cell Therapy with a PD-1 Knockout, In Patients with relapsed/refractory B cell Non-Hodgkin Lymphoma (r/r B-NHL): Updated Results from the Antler Phase 1 Clinical Trial
2026
·
Mehdi Hamadani
, Houston Holmes
, et al.
·
Transplantation and Cellular Therapy
·
3
Clinician and Administrator Perspectives on Chimeric Antigen Receptor (CAR) T-Cell Therapy Outpatient Administration in Relapsed or Refractory Multiple Myeloma (RRMM) in the United States
2024
·
Doris K Hansen
, Binod Dhakal
, et al.
·
Transplantation and Cellular Therapy
·
1
CT-452 Outpatient vs Inpatient Administration of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Cancer Patients: Systematic Literature Review
2023
·
Doris Hansen
, Yi-Hsuan Liu
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
PDF
Clinician and Administrator Perspectives on Chimeric Antigen Receptor (CAR) T-Cell Therapy Outpatient Administration in Relapsed or Refractory Multiple Myeloma (RRMM) in the United States (US): A Qualitative Study
2023
·
Doris K. Hansen
, Binod Dhakal
, et al.
·
Blood
POSTER: CT-452 Outpatient vs Inpatient Administration of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Cancer Patients: Systematic Literature Review
2023
·
Doris Hansen
, Yi-Hsuan Liu
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Assessing the Relationship between Glasgow Coma Scale Scores and MS Documentation in Allogeneic Hematopoietic Cell Transplant Recipients with Suspected Infection
2020
·
Mirta J. Maravilla-Rosas
, Lindsay McFarland
, et al.
·
Transplantation and Cellular Therapy
Implementing a Standardized Neurotoxicity Assessment for Immunotherapy Patients across an Inpatient and Outpatient Setting
2020
·
Lindsay McFarland
, Lenise Taylor
·
Transplantation and Cellular Therapy
Show more works
View as search
Works count:
10
Citation count:
53
H-index:
3
I10-index:
1
Year
Topic
Type